UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by ABLE Financial Group LLC

ABLE Financial Group LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 121.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,121 shares of the healthcare conglomerate's stock after buying an additional 2,259 shares during the period. ABLE Financial Group LLC's holdings in UnitedHealth Group were worth $2,084,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the company. Norges Bank purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $6,375,744,000. Raymond James Financial Inc. bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $1,914,740,000. Amundi boosted its stake in shares of UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock worth $3,183,132,000 after acquiring an additional 2,991,470 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares in the last quarter. Finally, Proficio Capital Partners LLC increased its position in UnitedHealth Group by 76,830.4% in the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock worth $955,388,000 after purchasing an additional 1,886,186 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CFO John F. Rex purchased 17,175 shares of the business's stock in a transaction on Friday, May 16th. The shares were bought at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer now owns 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction dated Friday, May 16th. The stock was bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.33% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the stock. Truist Financial reaffirmed a "buy" rating and issued a $360.00 price target (down previously from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. HSBC reiterated a "reduce" rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Erste Group Bank downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Royal Bank of Canada reduced their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Finally, Oppenheimer cut their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus target price of $441.87.

UnitedHealth Group Stock Down 0.2%

NYSE UNH traded down $0.58 during midday trading on Tuesday, hitting $294.99. 20,069,744 shares of the company traded hands, compared to its average volume of 6,655,522. The company has a market cap of $267.60 billion, a PE ratio of 19.03, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The company's 50-day simple moving average is $448.25 and its 200-day simple moving average is $501.48.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the business posted $6.91 earnings per share. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.